Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:NPD-1335 CAS:2376326-31-5 Purity:98% Package:100 mg;5 mg;50 mg
|
Company Name: |
RD International Technology Co., Limited
|
Tel: |
18024082417 |
Email: |
market@ubiochem.com |
Products Intro: |
Product Name:NPD-1335 CAS:2376326-31-5 Purity:5mg;10mg;50mg;100mg;250mg;500mg;1g Package:5mg;10mg;50mg;100mg;250mg;500mg;1g
|
|
| 2-Propynamide, 3-[5-[(4aR,8aS)-3,4,4a,5,8,8a-hexahydro-3-(1-methylethyl)-4-oxo-1-phthalazinyl]-2-methoxyphenyl]-N-(phenylmethyl)-, rel- Basic information |
Product Name: | 2-Propynamide, 3-[5-[(4aR,8aS)-3,4,4a,5,8,8a-hexahydro-3-(1-methylethyl)-4-oxo-1-phthalazinyl]-2-methoxyphenyl]-N-(phenylmethyl)-, rel- | Synonyms: | 2-Propynamide, 3-[5-[(4aR,8aS)-3,4,4a,5,8,8a-hexahydro-3-(1-methylethyl)-4-oxo-1-phthalazinyl]-2-methoxyphenyl]-N-(phenylmethyl)-, rel-;NPD-1335 | CAS: | 2376326-31-5 | MF: | C28H29N3O3 | MW: | 455.55 | EINECS: | | Product Categories: | | Mol File: | 2376326-31-5.mol | ![2-Propynamide, 3-[5-[(4aR,8aS)-3,4,4a,5,8,8a-hexahydro-3-(1-methylethyl)-4-oxo-1-phthalazinyl]-2-methoxyphenyl]-N-(phenylmethyl)-, rel- Structure](CAS/20210111/GIF/2376326-31-5.gif) |
| 2-Propynamide, 3-[5-[(4aR,8aS)-3,4,4a,5,8,8a-hexahydro-3-(1-methylethyl)-4-oxo-1-phthalazinyl]-2-methoxyphenyl]-N-(phenylmethyl)-, rel- Chemical Properties |
density | 1.17±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | Soluble in DMSO | pka | 12.42±0.46(Predicted) | form | Solid | color | Off-white to light yellow |
| 2-Propynamide, 3-[5-[(4aR,8aS)-3,4,4a,5,8,8a-hexahydro-3-(1-methylethyl)-4-oxo-1-phthalazinyl]-2-methoxyphenyl]-N-(phenylmethyl)-, rel- Usage And Synthesis |
Description | NPD1335 is a Trypanosoma brucei phosphodiesterase B1 (TbrPDEB1) inhibitor with submicromolar activities against T. brucei parasites. NPD1335 displays a greatly improved cytotoxicity profile. NPD1335 increases intracellular cAMP levels and results in the distortion of the cell cycle and cell death[1].
pKi: 6.9 (TbrPDEB1); pIC50: 6.2 (T. brucei) (NPD-1335)[1] | References | [1]. de Heuvel E, et al. Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2). Bioorg Med Chem. 2019 Jul 5. pii: S0968-0896(19)30790-4. |
| 2-Propynamide, 3-[5-[(4aR,8aS)-3,4,4a,5,8,8a-hexahydro-3-(1-methylethyl)-4-oxo-1-phthalazinyl]-2-methoxyphenyl]-N-(phenylmethyl)-, rel- Preparation Products And Raw materials |
|
Tag:2-Propynamide, 3-[5-[(4aR,8aS)-3,4,4a,5,8,8a-hexahydro-3-(1-methylethyl)-4-oxo-1-phthalazinyl]-2-methoxyphenyl]-N-(phenylmethyl)-, rel-(2376326-31-5)
Related Product Information
|